GB

Godavari Biorefineries Ltd

Q2 FY27

Godavari Biorefineries Q2 Results 2026: Net loss ₹15 Cr

Q2 FY27 earnings call: what management said on revenue, margins and capex.

Revenue
₹549Cr
+27.4% YoY
−1.6% QoQ
Net profit
−₹15Cr
Q2 FY26: −₹42 Cr
Margin
1.9%
+3.7 pp YoY
+1.8 pp QoQ

What the Q2 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned
Price₹226
Market cap₹1.2K Cr
P/E40.2

The short version

Bio-based specialty chemicals are the primary focus for future growth, aiming to increase their share of revenue. Bio-based chemicals business is the primary growth driver, targeting Rs. 240 crores quarterly revenue by Q3 FY '28 through debottlenecking and new product launches.

From Godavari Biorefineries Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.

How did Godavari Biorefineries' revenue grow in the September 2026 quarter?

Moderate growth
  • Bio-based specialty chemicals are the primary focus for future growth, aiming to increase their share of revenue.
  • The company targets bio-based chemical quarterly revenue to reach Rs. 240 crores by Q3 FY '28, up from Rs. 204 crores in Q2 FY '27.
  • Growth is driven by a combination of volume increases due to debottlenecking and higher realization/pricing.
  • Incremental growth will come from introducing new bio-based specialty chemicals and operational improvements.
  • Ethanol business to optimize multi-feedstock flexibility amid changing government policies, with some grain-based ethanol production expected.
  • Sugar and ethanol integrated business is seasonal, with Q3 and Q4 expected to deliver strong operational improvements.

2 more points from Godavari Biorefineries Ltd's call on revenue

Create a free account to keep reading this call

What happened to Godavari Biorefineries' margins in Q2 FY27?

See what Godavari Biorefineries Ltd said on profitability & margins — free account, 30 seconds.

What capex is Godavari Biorefineries planning?

Capex planned
  • Godavari Biorefineries is investing Rs. 25 crores for debottlenecking and adding capacity in bio-based specialty chemicals.
  • This Rs. 25 crore capex is expected to lead to business growth starting Q3 FY '28, with new or expanded specialty chemicals introduced in April to September of the next year.
  • The company’s larger capital allocation focus going forward will be on bio-based specialty chemicals rather than large capacity additions in ethanol.
  • Smaller investments may be made for ethanol facility optimization, but major investments will target bio-based specialty chemicals.

2 more points from Godavari Biorefineries Ltd's call on capex

Create a free account to keep reading this call

Is Godavari Biorefineries raising money or cutting debt?

See what Godavari Biorefineries Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Godavari Biorefineries' order book?

  • The grain-based distillery facility was commissioned at the end of Q1 FY27 and is currently operating at capacity to fulfill existing ethanol orders.
  • The company has taken contracts from oil marketing companies (OMCs) to supply ethanol.
  • Production is aligned with orders to deliver ethanol to these OMCs, indicating a stable orderbook for the ethanol-based program.
  • The bio-based chemicals segment is expanding, with ongoing debottlenecking and a target to reach Rs. 240 crores in quarterly revenue by Q3 FY28, showing expected order growth.

2 more points from Godavari Biorefineries Ltd's call on order book

Create a free account to keep reading this call

Godavari Biorefineries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Godavari Biorefineries Ltd Q2 FY27 results — key figures

Godavari Biorefineries Ltd Q2 FY27 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY27
Revenue549
Operating profit (EBITDA)10
Operating margin1.9%
Profit before tax-20
Net profit (PAT)-15
EPS (₹)-2.98

Source: Godavari Biorefineries Ltd's results filing to NSE (consolidated), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹549 Cr, net loss ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Godavari Biorefineries Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Godavari Biorefineries Ltd Q2 FY27 results?

Godavari Biorefineries reported a net loss of ₹15 Cr on revenue of ₹549 Cr (+27.4% YoY) in Q2 FY27.

What is Godavari Biorefineries Ltd share price analysis?

Godavari Biorefineries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 40.2 with a market cap of ₹1,159 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godavari Biorefineries Ltd planning capital expenditure?

Godavari Biorefineries is investing Rs. 25 crores for debottlenecking and adding capacity in bio-based specialty chemicals.

Keep Godavari Biorefineries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.